Stay updated on Ligelizumab in CSU Japanese Patients Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.

Latest updates to the Ligelizumab in CSU Japanese Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label updated to v3.5.0 and the previous label v3.4.3 was removed.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedNew site revision (v3.4.2) and removal of an outdated funding/operating-status notice (v3.4.1) appear to be general site maintenance updates rather than changes to study content or critical functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedAdded a site-wide notice about government funding lapse and open status, directing users to cc.nih.gov and opm.gov. Updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check71 days agoChange DetectedCosmetic updates include adding a 'Show glossary' option, capitalization tweaks for QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria'), a new 'No FEAR Act Data' label, and revision tag 'v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page shows a minor revision update: v3.3.4 replaces v3.3.3, with no changes to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ligelizumab in CSU Japanese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.